• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童中无明确危险因素的丙型肝炎血清流行率:系统评价和荟萃分析。

Seroprevalence of Hepatitis C in Children Without Identifiable Risk-Factors: A Systematic Review and Meta-Analysis.

机构信息

Department of Pediatrics, General Hospital TZANEIO, Piraeus.

Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens.

出版信息

J Pediatr Gastroenterol Nutr. 2021 Jun 1;72(6):e140-e148. doi: 10.1097/MPG.0000000000003099.

DOI:10.1097/MPG.0000000000003099
PMID:33633077
Abstract

OBJECTIVES

Hepatitis C virus (HCV) remains a major public health burden for >30 years since its discovery. It is estimated that >80 million people have been already infected. Direct-acting antiviral (DAA) treatment is now approved for young children over the age of 3 years. Treating children before the development of high-risk behaviors is optimal. Thus, assessing the current epidemiology of HCV in children becomes important and may promote awareness.

METHODS

Articles describing the prevalence of hepatitis C in children, were systematically reviewed. To assess HCV infection prevalence in the general population, studies discussing high-risk groups alone were excluded.

RESULTS

Data from 58 studies were analyzed. National data was scarce. An overall prevalence of HCV in children of 0.87% was found, ranging from 0.34% in Europe to 3.02% in Africa. Prevalence of viremic infection is important and data synthesis from available data indicated that HCV viremia was detected in 56.8% of children. The prevalence of HCV according to sex was described in 25 studies but no difference between sexes was detected. HCV prevalence was significantly higher in children older than 10 years (0.97%) when compared to those ages under 10 years old (0.75%, P < 0.001).

CONCLUSIONS

Considering probable underdiagnosis of HCV infection in children, this information reveals that prevalence is substantial. One may argue that future strategies aiming towards HCV elimination, may need to include antiviral treatment of pre-adolescent children as well.

摘要

目的

自丙型肝炎病毒 (HCV) 发现以来,其已成为 30 多年来的主要公共卫生负担。据估计,已有超过 8000 万人感染。直接作用抗病毒 (DAA) 治疗现已批准用于 3 岁以上的儿童。在儿童出现高危行为之前进行治疗是最佳选择。因此,评估 HCV 在儿童中的当前流行病学情况变得很重要,这可能会提高人们的认识。

方法

系统地回顾了描述儿童丙型肝炎流行情况的文章。为了评估普通人群中 HCV 感染的流行率,单独讨论高危人群的研究被排除在外。

结果

对 58 项研究的数据进行了分析。国家数据稀缺。发现儿童 HCV 的总体流行率为 0.87%,范围从欧洲的 0.34%到非洲的 3.02%。病毒血症感染的流行率很重要,从现有数据综合来看,56.8%的儿童检测到 HCV 病毒血症。有 25 项研究描述了 HCV 按性别流行的情况,但未发现性别之间存在差异。与 10 岁以下的儿童相比,10 岁以上的儿童 HCV 流行率(0.97%)明显更高(0.75%,P<0.001)。

结论

考虑到儿童 HCV 感染可能存在漏诊,这些信息表明其流行率相当高。人们可能会认为,未来旨在消除 HCV 的策略可能需要包括对青春期前儿童进行抗病毒治疗。

相似文献

1
Seroprevalence of Hepatitis C in Children Without Identifiable Risk-Factors: A Systematic Review and Meta-Analysis.儿童中无明确危险因素的丙型肝炎血清流行率:系统评价和荟萃分析。
J Pediatr Gastroenterol Nutr. 2021 Jun 1;72(6):e140-e148. doi: 10.1097/MPG.0000000000003099.
2
Global prevalence of hepatitis C virus in children in 2018: a modelling study.2018 年全球儿童丙型肝炎病毒感染率:一项建模研究。
Lancet Gastroenterol Hepatol. 2020 Apr;5(4):374-392. doi: 10.1016/S2468-1253(19)30385-1. Epub 2020 Jan 16.
3
Burden of pediatric hepatitis C.儿童丙型肝炎负担。
World J Gastroenterol. 2013 Nov 28;19(44):7880-8. doi: 10.3748/wjg.v19.i44.7880.
4
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.比利时丙型肝炎感染率低:对治疗报销和扩大规模的影响。
BMC Public Health. 2019 Jan 8;19(1):39. doi: 10.1186/s12889-018-6347-z.
5
Treating paediatric hepatitis C in the era of direct-acting antiviral agents.直接作用抗病毒药物时代的儿童丙型肝炎治疗。
Liver Int. 2021 Jun;41(6):1189-1200. doi: 10.1111/liv.14810. Epub 2021 Mar 8.
6
[Hepatitis C in a psychiatric setting: A forgotten reservoir?].[精神科环境中的丙型肝炎:一个被遗忘的传染源?]
Encephale. 2021 Apr;47(2):181-184. doi: 10.1016/j.encep.2020.03.003. Epub 2020 May 27.
7
Strategy for the Elimination of Hepatitis C in Cantabria.坎塔布里亚消除丙型肝炎战略。
Rev Esp Enferm Dig. 2020 Jul;112(7):565-570. doi: 10.17235/reed.2020.7108/2020.
8
HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality.欧洲丙型肝炎病毒相关疾病负担:发病率、患病率、发病率和死亡率的系统评估
BMC Public Health. 2009 Jan 22;9:34. doi: 10.1186/1471-2458-9-34.
9
Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.格鲁吉亚消除丙型肝炎计划的进展与挑战
J Hepatol. 2020 Apr;72(4):680-687. doi: 10.1016/j.jhep.2019.11.019. Epub 2019 Dec 4.
10
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.全球丙型肝炎病毒感染的流行病学:特定年龄组丙型肝炎病毒抗体血清流行率的新估计。
Hepatology. 2013 Apr;57(4):1333-42. doi: 10.1002/hep.26141. Epub 2013 Feb 4.

引用本文的文献

1
The Prevalence and Genotype Distribution of Hepatitis C Virus in Kenya: A Systematic Review and Meta-Analysis.肯尼亚丙型肝炎病毒的流行情况和基因型分布:系统评价和荟萃分析。
J Epidemiol Glob Health. 2024 Sep;14(3):677-689. doi: 10.1007/s44197-024-00299-1. Epub 2024 Sep 10.
2
Updated Clinical Guidelines on the Management of Hepatitis C Infection in Children.《儿童丙型肝炎感染管理的最新临床指南》
Pathogens. 2024 Feb 16;13(2):180. doi: 10.3390/pathogens13020180.
3
Real-World Efficacy and Safety of an 8-Week Glecaprevir/Pibrentasvir Regimen in Children and Adolescents with Chronic Hepatitis C-Results of a Multicenter EpiTer-2 Study.
一项多中心EpiTer-2研究的结果:8周格卡瑞韦/哌仑他韦方案治疗儿童和青少年慢性丙型肝炎的真实世界疗效和安全性
J Clin Med. 2023 Nov 6;12(21):6949. doi: 10.3390/jcm12216949.
4
Hepatitis C virus seroprevalence, testing, and treatment capacity in public health facilities in Ghana, 2016-2021; A multi-centre cross-sectional study.加纳公共卫生机构丙型肝炎病毒血清流行率、检测和治疗能力,2016-2021 年;一项多中心横断面研究。
PLoS One. 2023 Jun 23;18(6):e0287580. doi: 10.1371/journal.pone.0287580. eCollection 2023.